These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques. Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263 [TBL] [Abstract][Full Text] [Related]
5. Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein. Kano M; Matano T; Nakamura H; Takeda A; Kato A; Ariyoshi K; Mori K; Sata T; Nagai Y AIDS; 2000 Jun; 14(9):1281-2. PubMed ID: 10894297 [No Abstract] [Full Text] [Related]
6. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159 [TBL] [Abstract][Full Text] [Related]
7. No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication. Nieuwenhuis I; Beenhakker N; Bogers WM; Otting N; Bontrop RE; Dubois P; Mooij P; Heeney JL; Koopman G J Gen Virol; 2010 Dec; 91(Pt 12):2974-84. PubMed ID: 20826621 [TBL] [Abstract][Full Text] [Related]
8. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope. Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC J Immunol; 2002 Apr; 168(8):4001-11. PubMed ID: 11937557 [TBL] [Abstract][Full Text] [Related]
9. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Rose NF; Marx PA; Luckay A; Nixon DF; Moretto WJ; Donahoe SM; Montefiori D; Roberts A; Buonocore L; Rose JK Cell; 2001 Sep; 106(5):539-49. PubMed ID: 11551502 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques. De Rose R; Batten CJ; Smith MZ; Fernandez CS; Peut V; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Venturi V; Davenport MP; Kent SJ J Virol; 2007 Jan; 81(1):292-300. PubMed ID: 17050602 [TBL] [Abstract][Full Text] [Related]
11. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331 [TBL] [Abstract][Full Text] [Related]
12. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen. Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905 [TBL] [Abstract][Full Text] [Related]
13. Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques. Nacsa J; Radaelli A; Edghill-Smith Y; Venzon D; Tsai WP; Morghen Cde G; Panicali D; Tartaglia J; Franchini G Vaccine; 2004 Jan; 22(5-6):597-606. PubMed ID: 14741150 [TBL] [Abstract][Full Text] [Related]
14. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity. Mills KH; Barnard AL; Williams M; Page M; Ling C; Stott EJ; Silvera P; Taffs F; Kingsman AS; Adams SE J Immunol; 1991 Nov; 147(10):3560-7. PubMed ID: 1719081 [TBL] [Abstract][Full Text] [Related]
16. Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys. Santra S; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Lord CI; Pal R; Franchini G; Letvin NL J Immunol; 2002 Feb; 168(4):1847-53. PubMed ID: 11823518 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection. Soloff AC; Liu X; Gao W; Day RD; Gambotto A; Barratt-Boyes SM Eur J Immunol; 2009 Sep; 39(9):2437-49. PubMed ID: 19670380 [TBL] [Abstract][Full Text] [Related]
18. Recombinant subunit vaccines against primate lentiviruses. Hu SL AIDS Res Hum Retroviruses; 1996 Mar; 12(5):451-3. PubMed ID: 8882332 [No Abstract] [Full Text] [Related]
19. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628 [TBL] [Abstract][Full Text] [Related]
20. Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus-induced IL-2 expression by central memory CD4+ T lymphocytes. Sun Y; Schmitz JE; Acierno PM; Santra S; Subbramanian RA; Barouch DH; Gorgone DA; Lifton MA; Beaudry KR; Manson K; Philippon V; Xu L; Maecker HT; Mascola JR; Panicali D; Nabel GJ; Letvin NL J Immunol; 2005 Apr; 174(8):4753-60. PubMed ID: 15814700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]